Skip to main content

Breast Cancer

Online First
Breast Cancer
Simvastatin-Induced Rhabdomyolysis Potentially Triggered by Palbociclib Inhibition of CYP3A4: A Case Report
Madeleine Hosick, PharmD; Karam Abi Karam, DO; Kaitlyn Korah, PharmD; Kyla Bidne, PharmD, BCOP; Diana Tamer, PharmD, BCOP
Read More
Breast Cancer, Oncology
Radiation May Be Safely Omitted in Favorable-Risk Breast Cancer Patients Aged 50 to 69 Years
Read More
Breast Cancer, Oncology
Sacituzumab Govitecan Improves Progression-Free Survival in Metastatic Triple-Negative Breast Cancer with Brain Metastases
Phoebe Starr
Read More
Breast Cancer, Oncology
First-Line Pembrolizumab plus Chemotherapy Extend Progression-Free Survival in Patients with Metastatic Triple-Negative Breast Cancer
Phoebe Starr
Read More
Breast Cancer, Oncology
Pembrolizumab Added to First-Line Chemotherapy Improves Progression-Free Survival in Metastatic TNBC
Wayne Kuznar
Read More
Breast Cancer, Oncology
No Survival Benefit with Surgery and Radiation Added to Systemic Therapy in Patients with Newly Diagnosed Stage IV Breast Cancer
Phoebe Starr
Read More
Breast Cancer, FDA Approvals, Oncology
Enhertu, a Dual-Targeted Therapy, Approved for Metastatic HER2-Positive Breast Cancer
Read More
Breast Cancer, FDA Approvals, In the News, Multiple Myeloma, Pediatric Cancer, Oncology
Vincristine, Racial Disparities in Multiple Myeloma, and HER2 Metastatic Breast Cancer Are in the News
Read More
Breast Cancer, Oncology
MONALEESA-7 Sets New Standard of Care for Premenopausal Advanced Breast Cancer: Adding CDK4/6 to Endocrine Therapy Extends Survival
Phoebe Starr
Read More
Breast Cancer, FDA Approvals, In the News, Oncology
FDA Expands Indication for Kadcyla to Include the Adjuvant Treatment of HER2-Positive Early Breast Cancer
Read More
Page 1 of 3
Results 1 - 10 of 30